Federal health regulators said Friday that a highly-anticipated, experimental drug from Sanofi lowers bad cholesterol more than older drugs. But officials have questions about whether to approve the ...
In 2015, a new class of cholesterol-lowering injectable drugs called PCSK9-inhibitors was approved by the Food and Drug Administration (FDA) as a result of clinical research led by UT Southwestern. A ...
Gruthan Bioscience, LLC, a Medical University of South Carolina startup based in Charleston, South Carolina, received a Small Business technology Transfer (STTR) award from the National Heart, Blood ...
Egyptian fruit bats flew more slowly after eating alcohol-laced food. Now the urine strips that caught boozy wild chimps may be used on wild bats. Teen Heart Health Scores Average 68.3 in Ninth Grade ...
One of the world’s largest studies on the impact of cholesterol-lowering medication has highlighted an issue with a new class of drugs that could impair lung function in some patients. Image Credit: ...
New York, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cholesterol Lowering Drug Market Research Report by Class of Drug - Global Forecast to 2025 - ...
A single dose of the small interfering ribonucleic acid (siRNA) drug candidate ALN-PCS cut levels of LDL cholesterol (bad cholesterol) in healthy volunteers by up to 57%, and 40% on average more than ...
The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by injections, which could potentially broaden the use of cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results